e-learning
resources
Vienna 2012
Sunday, 02.09.2012
COPD comorbidities II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of metabolic syndrome in mortality rate of COPD patients: A five years follow up study
K. Schelini, S. Tanni, A. Zamuner, L. Coelho, S. Vale, R. Ferrari, L. Caram, I. Godoy, S. Paiva, I. Godoy (Botucatu, Brazil)
Source:
Annual Congress 2012 - COPD comorbidities II
Session:
COPD comorbidities II
Session type:
Thematic Poster Session
Number:
546
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Schelini, S. Tanni, A. Zamuner, L. Coelho, S. Vale, R. Ferrari, L. Caram, I. Godoy, S. Paiva, I. Godoy (Botucatu, Brazil). The influence of metabolic syndrome in mortality rate of COPD patients: A five years follow up study. Eur Respir J 2012; 40: Suppl. 56, 546
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
A prospective study on COPD and risk of mortality five years later
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Four-year follow up of a COPD cohort, participation and mortality
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial
Source: International Congress 2019 – Management of airway diseases in primary care
Year: 2019
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
The rates of admission for asthma patients in the last ten years
Source: Eur Respir J 2002; 20: Suppl. 38, 317s
Year: 2002
The impact of comorbidities on mortality in COPD, report from the OLIN COPD study.
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
15-years mortality in asthma-COPD overlap syndrome (ACOS) elderly population
Source: International Congress 2015 – Respiratory health across the life course
Year: 2015
Baseline differences in incident COPD patients who do and do not exacerbate in 2 years of follow up in the UK
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010
Covid-19 and gender: lower rate, but same mortality of severe disease in women
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Accelerated FEV
1
decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021
The impact of decreased 6MWT and exercise-induced desaturation on long-term survival and mortality related to Czech and Spanish phenotypes in patients with severe COPD
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Assessment of 10-year risk for cardiovascular disease in patients with overlap syndrome
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
The link between nocturnal desaturation, HR and overall heart rate variability in severe asthma patients
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Decline in function in preclinical COPD patients: a 6 years follow up study.
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017
COPD incidence in subjects with risk factors, chronic respiratory symptoms and normal spirometry: The PLATINO study>
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept